Skip to main content

Cost-effective reimbursement analysis for medical technologies in Europe

Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 15 EU countries

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Work plan for the development of specialised commissioning policies updated in England

On March 31, 2026, NHS England published an updated work plan for the development of Clinical Commissioning Policies for specialised services, reflecting the status as of March 23, 2026. 

Three new Med Tech-related policies were added to the work program:

  • Proton Beam Therapy in pregnancy;
  • Proton Beam Therapy in gastro-oesophageal cancers;
  • Transcatheter edge-to-edge repair of severe tricuspid regurgitation.

Furthermore, NHS England initiated a revision of Clinical Commissioning Policy on Transcatheter Aortic Valve Implantation (TAVI) for aortic valve disease (2013). 

No policies have been published since the previous update. The status of ongoing policies has also been revised.

See the full details here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.